Sign in

CIK 0001655759

  • Accelerated filer

ARVINAS, INC.

Sign in to watch
Ticker
ARVN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
472566120
Phone
+1 203-535-1456
Business address
395 WINCHESTER AVE, 5 SCIENCE PARK, NEW HAVEN, CT, 06511
Former names
ARVINAS INC., ARVINAS HOLDING COMPANY, LLC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,475
in 1 filing, $1K under 10b5-1 plans

Net −$1,475. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Loomis David K −$1K VP, Chief Accounting Officer sold <1% of stake
Date Insider Transaction Shares Price Value Owned after
2022-03-04 Taylor Ian Chief Scientific Officer Exercise or conversion +2,686 84,831
2022-03-04 Taylor Ian Chief Scientific Officer Sale −869 $63.94 $56K 83,962
2022-03-04 Taylor Ian Chief Scientific Officer Exercise or conversion · Restricted Stock Units −2,686 2,685
2022-03-04 Cassidy Sean A Chief Financial Officer Exercise or conversion +4,791 163,040
2022-03-04 Cassidy Sean A Chief Financial Officer Sale −1,593 $63.94 $102K 161,447
2022-03-04 Cassidy Sean A Chief Financial Officer Exercise or conversion · Restricted Stock Units −4,791 4,791
2022-03-04 Houston John G President and CEO Exercise or conversion +17,511 849,844
2022-03-04 Houston John G President and CEO Sale −6,024 $63.94 $385K 843,820
2022-03-04 Houston John G President and CEO Exercise or conversion · Restricted Stock Units −17,511 17,510
2022-03-01 Taylor Ian Chief Scientific Officer Exercise or conversion +3,500 $16.00 $56K 82,145
2022-03-01 Taylor Ian Chief Scientific Officer Exercise or conversion · Stock Option (right to buy) −596 0
2022-03-01 Taylor Ian Chief Scientific Officer Exercise or conversion · Stock Option (right to buy) −925 13,872
2022-03-01 Taylor Ian Chief Scientific Officer Exercise or conversion · Stock Option (right to buy) −1,979 6,964
2022-02-23 Taylor Ian Chief Scientific Officer Grant or award · Stock Option (right to buy) +67,000 67,000
2022-02-23 Cassidy Sean A Chief Financial Officer Grant or award · Stock Option (right to buy) +67,000 67,000
2022-02-23 Peck Ronald Chief Medical Officer Grant or award · Stock Option (right to buy) +67,000 67,000
2022-02-23 Houston John G President and CEO Grant or award · Stock Option (right to buy) +200,500 200,500
2022-02-15 Taylor Ian Chief Scientific Officer Exercise or conversion +20,000 $19.36 $387K 98,645
2022-02-15 Taylor Ian Chief Scientific Officer Sale −5,867 $71.74 $421K 92,778
2022-02-15 Taylor Ian Chief Scientific Officer Sale −5,766 $72.55 $418K 87,012

Page 11 of 32 · 628 trades